Combinatorial therapy for blood-stage Plasmodium infection: A pharmaceutical mixture encompassing Raltegravir and Aspirin decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 28/February/2018, 11.24 pm